IQVIA MedTech

Accelerate MedTech commercialization from insight to impact

Turn data, strategy, and execution into measurable MedTech market success - faster launches, stronger adoption, and sustained performance.
background accent graphic

MedTech commercialization & market access challenges

MedTech commercialization is more complex than ever. Increasing regulatory demands, pricing pressures, competitive dynamics, and operational constraints can lead to delayed launches, approval setbacks, recalls, reduced market access, and lower commercial performance.

IQVIA MedTech helps organizations navigate this complexity through integrated commercial solutions powered by predictive analytics, therapeutic expertise, industry-leading data, and AI-enabled technology. From market access and reimbursement to commercialization and lifecycle execution, we help accelerate adoption, improve efficiency, unlock growth potential, and reduce risk — so your innovation can thrive.

Market assessment & entry

IQVIA MedTech supports early‑stage and expansion‑stage medical device commercialization consulting with robust, MedTech‑specific market intelligence. Our approach reflects real‑world clinical practice, adoption variability, and site‑of‑care dynamics—enabling manufacturers to evaluate opportunity, risk, and readiness with clarity before investing or expanding.

Branding & positioning

Effective MedTech commercialization requires positioning that resonates with clinicians, health systems, patients, and payers. IQVIA MedTech helps manufacturers define and validate positioning using need‑gap analysis, competitive intelligence, and stakeholder insight - ensuring value propositions are credible, differentiated, and aligned with MedTech market access and reimbursement expectations.

Launch support

IQVIA MedTech enables high‑impact launches by aligning commercial, medical, and access strategies with execution. We help manufacturers navigate the complexity of MedTech market access consulting, reimbursement pathways, and evolving engagement models - while activating targeted launch execution that drives early adoption and sustained growth.

Performance measurement

IQVIA MedTech provides continuous visibility into commercial performance using trusted data and advanced analytics. Our performance measurement capabilities help manufacturers understand adoption, penetration, and brand impact - enabling faster, more informed optimization in dynamic MedTech markets.

Commercial execution

IQVIA MedTech delivers flexible, scalable MedTech commercialization services that evolve with portfolio needs and customer engagement models. From strategy to execution, we help manufacturers reduce complexity while improving consistency, effectiveness, and speed to market across the lifecycle.

Pill Shaped Accent Graphics

MedTech HCP engagement & compliance

Transform HCP engagement

Enable compliant, high‑impact engagement with physicians, surgeons, and healthcare professionals across the medical device lifecycle. IQVIA MedTech helps manufacturers modernize HCP collaboration by combining trusted reference data with purpose‑built digital platforms that simplify compliance, contracting, and payments at global scale.

Outcomes for MedTech manufacturers

  • 97% faster compliance approvals
  • 86% reduction in contracting time
  • 75% faster payments

Powered by IQVIA MedTech solutions

  • OneKey® provides a trusted global foundation for medical device HCP engagement, with data on 25M healthcare professionals across 117 countries and up to 1,000 data elements per profile, enabling accurate identification, targeting, and compliant engagement across commercial and medical interactions.
  • IQVIA MedTech Surgical Collaboration Platform enables compliant, digital collaboration with surgical stakeholders, supporting transparent approvals, efficient contracting, and consistent execution of HCP engagements.
IQVIA MedTech Recall and Field Action Support
Manage recalls with speed, control, and confidence
End-to-end management of product recalls and field actions is central to MedTech quality and compliance. IQVIA MedTech’s ISO 9001:2015 certified systems enable global support, digitized response, and onsite remediation, while our centralized tracking and real-time reporting processes streamline regulatory submissions and reduce operational burden.

Why MedTech businesses trust us

1600+

Medical device and diagnostics customers across 80+ countries

40+

Years of working with MedTech customers

15+

Therapeutic centers of excellence

1,000+

Diagnostic and surgical procedures covered

25M

Insights into 25M healthcare professionals across 6M organizations

96%

IQVIA MedTech recall programs achieve a 96% overall consignee response rate for field actions and product recalls.

We aim to be MedTech’s partner of choice by helping clients succeed in the market and improve patient outcomes. We do this through solutions designed specifically for MedTech and delivered by the most capable professionals in the industry.
MedTech is a completely unique space within the life science industry. Our experts have decades of experience with MedTech Market Access, Primary Intelligence, Strategy and Data – we translate our breadth of resources into specific solutions for medical device companies.
Todd Schaefer
VP & GM, MedTech Commercial Solutions
Ann Mayer
Sr Principal Consulting Services, IQVIA MedTech

Frequently Asked Questions

Navigating market access requires a blend of regulatory expertise, health economics, and payer engagement. Leveraging tailored strategies for coding, reimbursement, and value messaging can significantly reduce delays. With deep therapeutic knowledge and global-local insights, IQVIA MedTech helps innovators secure coverage and optimize value across regions like the US, EU, and APAC.
Effective sales enablement includes optimized team design, targeted training, segmentation, and KOL outreach. Empowering sales teams with consultative skills and AI-powered tools enhances adoption and revenue. IQVIA MedTech offers tailored programs and analytics to boost productivity and market penetration.
Yes, IQVIA MedTech has dedicated expertise tailored to Biologics & Combination Devices, In Vitro Diagnostics (IVD), Medical Devices, and Digital Health. Our teams handle qualitative and quantitative primary market research, navigate complex regulatory pathways, execute targeted campaign strategies, and coordinate field teams to drive diagnostic adoption and market access globally.
We measure performance through our Connected Intelligence platform, using predictive analytics and real-time data feeds across global markets: KPI Dashboards: Track lifecycle performance and continuous optimization from launch through post-market - MedTech Market Monitor: Benchmarks surgical procedure volumes across 950 surgeries in 45 countries - Data Device Link: Evaluates commercial success and product efficacy by connecting medical device usage data directly to real-world patient outcomes.
Yes, IQVIA MedTech’s ValueTrak Contract Management services solves the challenges of fragmented contract data. ValueTrak connects real-time sales and charge-back data, simplifying compliance tracking and optimizing overall contract performance across payers and providers.
IQVIA MedTech manages the entire recall lifecycle with over 3,500 dedicated recall specialists who deploy rapidly across global markets. Our services include multilingual outreach, concierge-level support, and professional field teams to protect brand reputation, maintain customer trust, and ensure business continuity.
Successful launches hinge on integrated planning—from brand positioning and stakeholder engagement to multi-channel campaign execution. Data-driven segmentation, KOL activation, and coordinated team alignment are essential. These elements are central to IQVIA MedTech’s launch frameworks, which guide clients through every stage of market entry to ensure impact and adoption.
Achieving reimbursement involves demonstrating product value through health economics and outcomes research (HEOR), optimizing coding pathways, and crafting payer-aligned messaging. IQVIA MedTech supports this with comprehensive evidence packages, pre-authorization support, and strategic payer engagement to streamline access and minimize delays.
Post-launch success depends on real world evidence (RWE) generation, performance tracking, and stakeholder feedback. Monitoring product performance and refining access strategies are key to sustained growth. IQVIA MedTech integrates RWE, market analytics, and surveillance to support lifecycle value and regulatory compliance.
Advanced analytics, KPI dashboards, and automated reporting systems are vital for tracking performance across the product lifecycle. Real-time insights into spend, ROI, and territory impact enable agile strategy refinement. IQVIA MedTech’s platforms provide these capabilities, helping clients optimize outcomes and drive growth.